These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9250408)

  • 41. Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.
    Hoff HF; O'Neil J; Wu Z; Hoppe G; Salomon RL
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):275-82. PubMed ID: 12588771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.
    Murthi KK; Friedman LR; Oleinick NL; Salomon RG
    Biochemistry; 1993 Apr; 32(15):4090-7. PubMed ID: 8471616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chemiluminescence of low density lipoproteins activated by coumarin in the presence of divalent iron ions].
    Vladimirov IuA; Sherstnev MP; Azimbaev TK
    Biofizika; 1995; 40(2):323-7. PubMed ID: 7578338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of narrow mass-window, high-resolution extracted product ion chromatograms for the sensitive and selective identification of protein modifications.
    Spickett CM; Reis A; Pitt AR
    Anal Chem; 2013 May; 85(9):4621-7. PubMed ID: 23534669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.
    Carrier EJ; Amarnath V; Oates JA; Boutaud O
    Biochemistry; 2009 Nov; 48(45):10775-81. PubMed ID: 19824699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A method for thermal generation of aryloxyl radicals at ambient temperatures: application to low-density lipoprotein (LDL) oxidation.
    Paul T; Ingold KU
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):804-6. PubMed ID: 12491342
    [No Abstract]   [Full Text] [Related]  

  • 47. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis.
    Salomon RG
    Ann N Y Acad Sci; 2005 Jun; 1043():327-42. PubMed ID: 16037255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
    Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
    Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative determination of low density lipoprotein oxidation by FTIR and chemometric analysis.
    Lam HS; Proctor A; Nyalala J; Morris MD; Smith WG
    Lipids; 2004 Jul; 39(7):687-92. PubMed ID: 15588027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidized phospholipids as a new landmark in atherosclerosis.
    Itabe H
    Prog Lipid Res; 1998; 37(2-3):181-207. PubMed ID: 9829125
    [No Abstract]   [Full Text] [Related]  

  • 51. Levuglandin E2 crosslinks proteins.
    Iyer RS; Ghosh S; Salomon RG
    Prostaglandins; 1989 Apr; 37(4):471-80. PubMed ID: 2762557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolevuglandin adducts in disease.
    Salomon RG; Bi W
    Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidized low density lipoproteins bind to collagen by negative-charge-dependent mechanisms.
    Jimi S; Sakata N; Takebayashi S
    Ann N Y Acad Sci; 1995 Jan; 748():609-12. PubMed ID: 7695215
    [No Abstract]   [Full Text] [Related]  

  • 54. Biochemical, structural, and functional properties of oxidized low-density lipoprotein.
    Esterbauer H; Dieber-Rotheneder M; Waeg G; Striegl G; Jürgens G
    Chem Res Toxicol; 1990; 3(2):77-92. PubMed ID: 2130945
    [No Abstract]   [Full Text] [Related]  

  • 55. Induction of protein oxidation in human low density lipoprotein by the photosensitive organic hydroperoxide, N,N'-bis(2-hydroxyperoxy-2-methoxyethyl)-1,4,5,8-naphthalene-tetra-carb oxylic- diimide.
    Matsugo S; Yan LJ; Han D; Packer L
    Biochem Biophys Res Commun; 1995 Jan; 206(1):138-45. PubMed ID: 7818513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using peroxynitrite as oxidant with low-density lipoprotein.
    Patel RP; Darley-Usmar VM
    Methods Enzymol; 1996; 269():375-84. PubMed ID: 8791666
    [No Abstract]   [Full Text] [Related]  

  • 57. Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA.
    Carrier EJ; Zagol-Ikapitte I; Amarnath V; Boutaud O; Oates JA
    Biochemistry; 2014 Apr; 53(15):2436-41. PubMed ID: 24684440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational changes in oxidized LDL using X-ray and neutron solution scattering techniques.
    Meyer DF; Nealis AS; Bruckdorfer KR; Perkins SJ
    Biochem Soc Trans; 1993 May; 21(2):139S. PubMed ID: 8359393
    [No Abstract]   [Full Text] [Related]  

  • 59. 3-Nitrotyrosine in human serum albumin and low density lipoproteins.
    Khan J; Bruckdorfer KR; Jacobs M
    Biochem Soc Trans; 1997 Aug; 25(3):394S. PubMed ID: 9388624
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular Structures of Isolevuglandin-Protein Cross-Links.
    Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
    Chem Res Toxicol; 2016 Oct; 29(10):1628-1640. PubMed ID: 27599534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.